1. 1-24 of 900 1 2 3 4 ... 36 37 38 »
    1. Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.

      Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.

      Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced the appointment of Diana F. Hausman, M.D., Chief Medical Officer of Lengo Therapeutics (a wholly-owned subsidiary of Blueprint Medicines Corporation), to its Board of Directors...

      Read Full Article
    1-24 of 900 1 2 3 4 ... 36 37 38 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content